Final results of the HIV prevention study VOICE are published in NEJM

(Microbicide Trials Network) Researchers who conducted the VOICE study involving more than 5,000 women in Africa detail in the NEJM how none of the products (tenofovir, Truvada and tenofovir vaginal gel) was effective in preventing HIV and the extent that women did not use them. Tests of blood indicate nonuse began early; many women never used the products. Yet, among women in the tenofovir gel group whose blood tests indicated use, HIV risk was reduced by 66 percent.

http://www.eurekalert.org/pub_releases/2015-02/mtn-fro020215.php

Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2015 Category: Infectious Diseases Source Type: news